Advertisement
Home Tags Cancer: Ovarian

Tag: Cancer: Ovarian

Limiting ovarian cancer surgery to high-volume surgeons and hospitals to improve survival could restrict care at many low-volume centers with better-than-expected outcomes

Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric

0
Minimum-volume standards could restrict care at many centers with better-than-expected outcomes

American College of Obstetricians and Gynecologists, May 3-6

0
The 67th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists The annual meeting of the American College of Obstetricians and...
Only one-quarter of those with breast cancer and one-third with ovarian cancer undergo genetic testing

Genetic Testing Underused in Breast, Ovarian Cancer

0
Pathogenic variants ID'd in 7.8 percent of patients with breast cancer, 14.5 percent with ovarian cancer
Women with recurrent ovarian cancer who receive the poly ADP ribose polymerase inhibitor niraparib as maintenance therapy after treatment have both more time without side effects and significantly longer progression-free survival than those on placebo

Niraparib Extends Time Without Symptoms in Ovarian Cancer

0
Findings based on phase 3 study of maintenance therapy with PARP inhibitor following treatment
For patients with advanced ovarian cancer who have undergone intra-abdominal macroscopically complete resection and have clinically negative lymph nodes

Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer

0
Findings seen after intra-abdominal macroscopically complete resection with normal lymph nodes
Johnson & Johnson is being investigated by the U.S. Justice Department and the U.S. Securities and Exchange Commission over possible asbestos contamination of the company's baby powder and other talc-based products.

U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc

0
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
Artificial intelligence software can predict prognosis in epithelial ovarian cancer above established prognostic methods

Artificial Intelligence Predicts Survival in Epithelial Ovarian Cancer

0
Radiomic Prognostic Vector IDs patients with median overall survival of less than two years
The risk for malignancy and acute complications is low for patients with an adnexal mass with benign ultrasound morphology who are managed conservatively

Conservative Management Feasible for Adnexal Masses

0
Risk for malignancy, acute complications low for adnexal mass with benign ultrasound morphology
Many women are not knowledgeable about ovarian cancer before diagnosis despite most women experiencing prediagnosis symptoms

Many Women Have Not Heard of Ovarian Cancer Before Dx

0
Nine in 10 women experience multiple symptoms prediagnosis; eight in 10 of them consult a doctor
Low-dose aspirin use is associated with a reduced risk for ovarian cancer

Low-Dose Aspirin May Reduce Ovarian Cancer Risk

0
Inverse association for low-dose but not standard-dose aspirin with ovarian cancer risk